Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICOLO: Clopidogrel in Neonates and Infants
NCT00115375Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of clopidogrel in thrombosis (5 arms), sponsored by Sanofi. Primary endpoint: Percent inhibition of maximum extent and rate of 5 µM ADP-induced platelet aggregation. Started Jan 2004; status: completed.
02
Drugs
clopidogrel
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00115375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115375.